MedTrace Logo

Development and Assessment of a Spanish-Language Hearing Loss Toolkit for Self-Management

NCT04534387 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2023-05-09

No results posted yet for this study

Summary

The objective of this application is to develop and evaluate Spanish-language hearing education materials for adults. Our hypothesis is that participants will demonstrate better understanding of their hearing loss and associated difficulties, and will be better able to identify options for self-management following delivery of culturally and linguistically appropriate patient education materials.

Conditions

Interventions

OTHER

Spanish-Language Hearing Loss Toolkit for Self-Management

The materials include printed information and images designed to increase hearing loss knowledge and focus on self-management topics such as the fundamentals of the ear and hearing, communication strategies, speech understanding in noise, and hearing technology.

OTHER

American Speech-Language-Hearing Association (ASHA) Audiology Series Spanish Language Handouts

Standard of care patient education handouts developed by ASHA in the Spanish language.

Sponsors & Collaborators

  • National Institute on Deafness and Other Communication Disorders (NIDCD)

    collaborator NIH

  • University of South Florida

    lead OTHER

Principal Investigators

  • Michelle Arnold, Au.D., Ph.D. · University of South Florida

  • Victoria Sanchez, Au.D., Ph.D. · University of South Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-22
Primary Completion
2024-03-30
Completion
2024-03-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04534387 on ClinicalTrials.gov